Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma
about
Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsA pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resectionEffect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic functionPrognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic reviewPreoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinomaThe association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.Lymphopenia and its association with survival in patients with locally advanced cervical cancer.Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.Prognostic Value of the Combination of Preoperative Hemoglobin, Lymphocyte, Albumin, and Neutrophil in Patients with Locally Advanced Colorectal CancerPreoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.The immune network in pancreatic cancer development and progression.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection.Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.Prognostic impact of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in nasopharyngeal carcinoma: A retrospective study of 180 Taiwanese patients.Combined analysis of the preoperative and postoperative prognostic nutritional index offers a precise predictor of the prognosis of patients with gastric cancer.The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma.Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers.C-Reactive protein: a major inflammatory biomarkerComparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinomaSystemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors
P2860
Q26781538-4F249727-8F5E-4848-8D06-E83AA1EABBB7Q33641729-ECBFA382-0C52-414F-A1DA-EB53DCE55970Q35174270-D87AF6C0-74E1-4C64-8E1A-CFA9B3E2C8A0Q35202177-B14BC2AB-AD5B-498C-9E89-D60D6B1BB095Q35797850-FB527C41-D317-407D-BC04-C781FFB6DBB5Q35881343-BCA4E390-A401-411D-BD2C-AFF4A29D0985Q35905788-8AEDAD49-9310-459C-BA9F-C3B22F595E23Q36174677-D854A876-9023-4744-AA1D-081E67BE03FEQ36301765-37B7378C-D076-47EB-AD67-FBF49C739144Q36569129-9149792F-4B67-492A-A4F5-3BBAD81B0F70Q36663622-46DEBB99-7802-4225-BB8C-4BDF6B6869A3Q36729590-D3395921-AA43-4A41-AEFB-F717064FED1DQ37040624-C6D9C229-BD5D-4247-A87C-48BAEDB7272AQ37540276-2F72B1C1-0B04-448D-9969-90AD27075E5AQ37639239-FD32B270-1BD8-4D42-B1BC-C2A01F6A9706Q37689991-4ABD627C-3019-456E-B889-1382D996E7BCQ37710295-70A7EC6F-88AF-467F-AFA0-3D7A2DBB30EAQ38121412-FF9D93FF-149B-4161-9A84-401982A221F0Q38927638-10DAC042-F1B8-4D69-AC37-D7E56EF5BA56Q39062109-9B7EB229-3EF7-416A-89BD-9C8E9F57B50BQ40877283-1672620E-F675-4D87-9080-0B13B171D944Q41259916-F9BEF3C7-8D1E-4B10-B49B-73B5E80FB815Q41644002-510756D9-1055-44EC-BEC5-3FAF832927E6Q42684243-B2011544-B51A-4C58-A99C-6D610ECF6073Q42985641-6DADACA0-59FE-48DB-92BD-B79BB0194FA5Q47630575-CB9AE23B-0CBF-47B2-B3F1-E2CD3C70E3D5Q50063240-6D8A6FC8-3356-417F-A7B5-106E972056A7Q50581538-CFB87A9A-A7CE-4D34-AEE3-B01CC28A9B9EQ50967431-9F62FC25-D4A7-44C1-AD08-91B8CB53439AQ52925618-011053B0-9214-4080-B4EF-F072D63A9F10Q53244866-FB522EF6-45EE-46A1-B964-DEDB47F9D529Q55514013-A0E39654-9702-4E15-82BB-9D8CD5325D1FQ57818432-F17610DD-C2B4-4AF7-A6E9-D8EE9482D2B6Q58751124-564EF377-25F1-4CBB-8067-FFAC01630E0AQ59132270-2DF36CF7-D572-4F33-AFC5-1FD854AF74CE
P2860
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@ast
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@en
type
label
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@ast
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@en
prefLabel
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@ast
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@en
P2093
P2860
P1476
Preoperative lymphocyte count ...... ncreatic ductal adenocarcinoma
@en
P2093
P2860
P304
P356
10.1080/13651820701774891
P50
P577
2007-01-01T00:00:00Z